Remove Invention Remove Inventor Remove Patent Infringement Remove Settlement
article thumbnail

Unlocking Success: The Power of Patents in Entrepreneurship – What Meta’s Settlement with Voxer Teaches Us

LexBlog IP

Patents are so important to your success! As an inventor, there’s nothing more thrilling than having a big corporation take interest in your idea. What if the company decides to sever ties or even worse, continue using your invention without your permission? This is where patenting becomes essential.

article thumbnail

Gilead and ViiV Healthcare Settle Global Patent Dispute for Over $1B USD

IPilogue

This article delves into the legal doctrines that support the parties’ claims and the overarching strategy to their settlement. ViiV alleges Gilead infringed upon patent 385 under the doctrine of equivalents, which has two exclusions: dedication-disclosure and specific exclusion. sales of Biktarvy. Concluding Remarks.

Patent 120
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Patent Eligibility Jurisprudence

Patently-O

Like the dissenting judge on the panel, several of the opinions denying rehearing en banc faulted the panel majority for establishing a new “nothing more” test—if the claimed invention “clearly invokes a natural law, and nothing more, to accomplish a desired result”—for patent ineligibility. at 1366 (O’Malley J.,

Patent 102
article thumbnail

India’s High Court of Delhi issues guidance on SEP licensing that seeks to harmonize decisions in other countries (Intex v. Ericsson)

LexBlog IP

treating the Standard Essential Patent as akin to a ‘ransom strip’ of land).” ” Hold Out : “‘Hold out’ occurs if an implementer is able to implement a technical solution covered by a Standard Essential Patent without paying the reasonable market value for a licence (or perhaps anything at all).

article thumbnail

Biosimilars 2021 Year in Review

Fish & Richardson Trademark & Copyright Thoughts

No earlier than 2023 per settlement. No earlier than 2023 per settlement. No earlier than 2023 per settlement. . No earlier than 2023 per settlement. No earlier than 2023 per settlement. No earlier than 2023 per settlement. No earlier than 2023 per settlement. Commercial Launch Date. adalimumab-aqvh.